Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 12-May-23 5:00 PM View:  | Allovir, Inc. (ALVR) | 11-May-23 | Grant | 35,000 | -- | -- | < 1% 23.63M to 23.66M | |
| 01-Aug-22 4:35 PM View: | Allovir, Inc. (ALVR) | 28-Jul-22 | Grant | 8,152,250 | $4.61 | $37,581,900.00 | 44% 18.38M to 26.53M | |
| 28-Jun-22 9:24 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 24-Jun-22 | Payment of Exercise | 45,078 | $13.39 | $603,594.00 | (< 1%) 4.57M to 4.53M | |
| 28-Jun-22 9:24 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 24-Jun-22 | Option Exercise | 140,374 | $4.30 | $603,608.00 | 3% 4.43M to 4.57M | |
| 15-Nov-21 5:17 PM View: | Allovir, Inc. (ALVR) | 10-Nov-21 | Market Sale (Planned) | 800 | $24.76 | $19,812.00 | (< 1%) 18.38M to 18.38M | 10% |
| 09-Nov-21 6:43 PM View: | Allovir, Inc. (ALVR) | 09-Nov-21 | Market Sale (Planned) | 3,815 | $24.79 | $94,567.00 | (< 1%) 18.39M to 18.38M | 3% |
| 09-Nov-21 6:43 PM View: | Allovir, Inc. (ALVR) | 05-Nov-21 | Market Sale (Planned) | 8,381 | $24.80 | $207,888.00 | (< 1%) 18.39M to 18.39M | 3% |
| 29-Oct-21 5:02 PM View: | Allovir, Inc. (ALVR) | 27-Oct-21 | Market Sale (Planned) | 2,200 | $24.78 | $54,510.50 | (< 1%) 18.4M to 18.39M | 4% |
| 25-Oct-21 6:24 PM View: | Allovir, Inc. (ALVR) | 25-Oct-21 | Market Sale (Planned) | 7,769 | $24.82 | $192,813.00 | (< 1%) 18.4M to 18.4M | < 1% |
| 25-Oct-21 6:24 PM View: | Allovir, Inc. (ALVR) | 22-Oct-21 | Market Sale (Planned) | 5,723 | $24.77 | $141,757.00 | (< 1%) 18.41M to 18.4M | < 1% |
| 25-Oct-21 6:24 PM View: | Allovir, Inc. (ALVR) | 21-Oct-21 | Market Sale (Planned) | 100 | $24.75 | $2,475.00 | (< 1%) 18.41M to 18.41M | < 1% |
| 14-Jan-21 5:30 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 12-Jan-21 | Conversion | 5,826,830 | -- | -- | 5179% 112.51K to 5.94M | |
| 14-Jan-21 5:30 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 12-Jan-21 | Purchase | 200,000 | $21.00 | $4,200,000.00 | 3% 5.94M to 6.14M | |
| 06-Aug-20 6:06 AM View: | Allovir, Inc. (ALVR) | 03-Aug-20 | Conversion | 15,479,400 | -- | -- | 51260% 30.2K to 15.51M | |
| 06-Aug-20 6:06 AM View: | Allovir, Inc. (ALVR) | 03-Aug-20 | Purchase | 2,900,000 | $17.00 | $49,300,000.00 | 19% 15.51M to 18.41M | |
| 20-Dec-19 5:31 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 20-Dec-19 | Disposition (other) | 600,000 | -- | -- | (21%) 2.84M to 2.24M | |
| 20-Dec-19 5:31 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 19-Dec-19 | Market Sale | 41,965 | $16.47 | $691,222.00 | (1%) 2.88M to 2.84M | (17%) |
| 20-Dec-19 5:31 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 18-Dec-19 | Market Sale | 2,891 | $17.01 | $49,164.30 | (< 1%) 2.88M to 2.88M | (13%) |
| 11-Dec-19 7:09 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 11-Dec-19 | Market Sale | 7,743 | $17.65 | $136,683.00 | (< 1%) 2.89M to 2.88M | (9%) |
| 11-Dec-19 7:09 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 10-Dec-19 | Market Sale | 56,830 | $17.62 | $1,001,530.00 | (2%) 2.95M to 2.89M | (9%) |
| 11-Dec-19 7:09 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 09-Dec-19 | Market Sale | 139,989 | $17.65 | $2,470,960.00 | (5%) 3.09M to 2.95M | (9%) |
| 24-Oct-19 6:36 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 22-Oct-19 | Market Sale | 3,888 | $15.16 | $58,930.80 | (< 1%) 4.25M to 4.25M | (27%) |
| 24-Sep-19 8:27 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 23-Sep-19 | Market Sale | 11,321 | $17.31 | $195,982.00 | (< 1%) 3.1M to 3.09M | (11%) |
| 24-Sep-19 8:27 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 20-Sep-19 | Market Sale | 405,000 | $17.94 | $7,263,840.00 | (12%) 3.51M to 3.1M | (7%) |
| 05-Sep-19 4:32 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 04-Sep-19 | Market Sale | 12,214 | $17.55 | $214,414.00 | (< 1%) 3.52M to 3.51M | (9%) |
| 05-Sep-19 4:32 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 03-Sep-19 | Market Sale | 10,559 | $17.01 | $179,653.00 | (< 1%) 3.53M to 3.52M | (13%) |
| 05-Sep-19 4:32 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 29-Aug-19 | Market Sale | 3,700 | $17.01 | $62,925.20 | (< 1%) 3.53M to 3.53M | (13%) |
| 05-Sep-19 4:32 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 28-Aug-19 | Market Sale | 6,700 | $17.01 | $113,941.00 | (< 1%) 3.54M to 3.53M | (13%) |
| 05-Sep-19 4:32 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 27-Aug-19 | Market Sale | 1,200 | $17.01 | $20,413.60 | (< 1%) 3.54M to 3.54M | (13%) |
| 05-Sep-19 4:32 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 26-Aug-19 | Market Sale | 29,128 | $17.01 | $495,479.00 | (< 1%) 3.57M to 3.54M | (13%) |
| 05-Sep-19 4:32 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 23-Aug-19 | Market Sale | 3 | $17.00 | $51.00 | (< 1%) 3.57M to 3.57M | (13%) |
| 05-Sep-19 4:32 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 22-Aug-19 | Market Sale | 100 | $17.03 | $1,703.00 | (< 1%) 3.57M to 3.57M | (13%) |
| 05-Sep-19 4:32 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 21-Aug-19 | Market Sale | 500 | $17.00 | $8,500.00 | (< 1%) 3.57M to 3.57M | (13%) |
| 21-Feb-19 5:01 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 19-Feb-19 | Conversion | 2,904,590 | -- | -- | 100% 0 to 2.9M | |
| 21-Feb-19 5:01 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 19-Feb-19 | Purchase Duplicate | 666,667 | $15.00 | $10,000,000.00 | 23% 2.9M to 3.57M | |
| 12-Jan-15 4:40 PM View: | Radius Health, Inc. (RDUS) | 08-Jan-15 | Disposition (other) Duplicate | 389,331 | -- | -- | (9%) 4.22M to 3.83M | |
| 15-Jan-15 5:03 PM View: | Radius Health, Inc. (RDUS) | 15-Jul-14 | Disposition (other) | 335,820 | -- | -- | (8%) 4.17M to 3.83M | |
| 15-Jan-15 5:03 PM View: | Radius Health, Inc. (RDUS) | 10-Jul-14 | Disposition (other) | 251,680 | -- | -- | (6%) 4.42M to 4.17M | |
| 13-Jun-14 10:13 AM View: | Radius Health, Inc. (RDUS) | 11-Jun-14 | Conversion | 2,666,830 | -- | -- | 171% 1.56M to 4.22M | |
| 13-Jun-14 10:13 AM View: | Radius Health, Inc. (RDUS) | 11-Jun-14 | Purchase | 587,500 | $8.00 | $4,700,000.00 | 14% 4.22M to 4.81M | |
| 10-Jun-14 3:28 PM View: | Radius Health, Inc. (RDUS) | 06-Jun-14 | Conversion Duplicate | 1,557,330 | -- | -- | 100% 0 to 1.56M |